Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma [4]

Histopathology

Volumn 50, Issue 2, 2007, Pages 284-285

  Fernandez Flores, A ^a  

^a Service of Cellular Pathology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; PURINE P2X7 RECEPTOR; UVOMORULIN;

APOPTOSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; HUMAN; KERATOACANTHOMA; LETTER; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; KERATOACANTHOMA; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33845979089     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02582.x     Document Type: Letter

References (18)

1. Slater M, Barden JA. Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers. Histopathology 2005; 47; 170-178.
2. Groschel-Stewart U, Bardini M, Robson T, Burnstock G. Localisation of P2X5 and P2X7 receptors by immunohistochemistry in rat stratified squamous epithelia. Cell Tissue Res. 1999; 296; 599-605.
3. Greig AV, Linge C, Cambre A, Burnstock G. Purinergic receptors are part of a signalling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis. J. Invest. Dermatol. 2003; 121; 1145-1149.
4. Greig AV, Ling C, Terenghi G, McGrouthre DA, Burnstock G. Prurinergic receptors are part of a functional signalling system for proliferation and differentiation of human epidermal keratinocytes. J. Invest. Dermatol. 2003; 120; 1007-1015.
5. Georgiou JG, Skarratt KK, Fuller SJ et al. Human epidermal and monocyte-derived Langerhans cells express functional P2X receptors. J. Invest. Dermatol. 2005; 125; 482-490.
6. Reefman E, Limburg PC, Kallenberg CG, Bijil M. Apoptosis in human skin: role in pathogenesis of various diseases and relevance for therapy. Ann. NY Acad. Sci. 2005; 1051; 52-63.
7. Seitz CS, Freiberg RA, Hinata K, Khavari PA. NF-kappaB determines localization and features of cell death in epidermis. J. Clin. Invest. 2000; 105; 253-260.
8. Haake RA, Polakowska RR. Cell death by apoptosis in epidermal biology. J. Invest. Dermatol. 1993; 101; 107-112.
9. Teraki Y, Shiohara T. Apoptosis and the skin. Eur. J. Dermatol. 1999; 9; 413-426.
10. Paus R, Rosenbach T, Haas N, Czarnetzki BM. Patterns of cell death: the significance of apoptosis for dermatology. Exp. Dermatol. 1993; 2; 3-11.
11. Norris D. Differential control of cell death in the skin. Arch. Dermatol. 1995; 131; 945-948.
12. Weisfelner ME, Gottlieb AB. The role of apoptosis in human epidermal keratinocytes. J. Drugs Dermatol. 2003; 2; 385-391.
13. Schwarzeberger K, Udey MC. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell e-cadherin expression in situ. J. Invest. Dermatol. 1996; 106; 553-558.
14. Trautmann A, Kruger K, Akdis M et al. Apoptosis and loss of adhesion of bronchial epithelial cells in asthma. Int. Arch. Allergy Immunol. 2005; 138; 142-150.
15. Dubikov AI, Belogolovykh LA, Medved EE. Apoptosis as a mechanism of autoimmune inflammation in human knee joint. Bull. Exp. Biol. Med. 2004; 138; 568-570.
16. Semmler A, Okulla T, Sastre M, Dumitrescu-Ozimek L, Heneka MT. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J. Chem. Neuroanat. 2005; 30; 144-157.
17. Lyakhovitsky A, Barzilai A, Fogel M, Trau H, Huszar M. Expression of e-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors. Am. J. Dermatopathol. 2004; 26; 372-378.
18. Papadavid E, Pignatelli M, Zakynthinos S, Krausz T, Chu AC. The potential role of abnormal e-cadherin and alpha-, beta-, and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma. Br. J. Dermatol. 2001; 145; 582-589.